Hive Smart Implant Exploration
Spinal Fusion
Pre-clinical R&DActive
Key Facts
About NanoHive Medical
NanoHive Medical is an innovator in the orthopedic spine sector, focusing on next-generation spinal fusion implants. Its core technology is the Soft Titanium® lattice, a patented, 3D-printed structure that mimics cancellous bone, offering a modulus of elasticity comparable to traditional polymer (PEEK) implants while maintaining titanium's strength and biocompatibility. The company has a commercial portfolio of cervical and lumbar interbody devices and is exploring future 'smart implant' capabilities. With recent Series C funding and distribution expansion, NanoHive is positioned to grow its market share in the competitive spinal implants industry.
View full company profileTherapeutic Areas
Other Spinal Fusion Drugs
| Drug | Company | Phase |
|---|---|---|
| JAZBI™ Cubes | SDIP Innovations | Preclinical |
| Expandable Interbody Portfolio | Globus Medical | Iterative Development |
| Mimetic Metal Technology Development | CoreLink Surgical | Development/Commercial |
| Bone Graft Substitute | BiologicsMD | Pre-clinical |
| VisuALIF | SpineSmith | Commercial |
| ASTRO Registry | Artoss | Post-Market |
| ProLift Pivot Expandable Spacer System | Life Spine | FDA Cleared |
| NEXXT MATRIXX Clinical Evidence Study | Nexxt Spine | Post-Market Study |
| AGA111 | Angitia Biopharmaceuticals | Phase 3 |
| X-PAC® Portfolio Expansion | Expanding Innovations | Development |
| SOLACE™ | Xenix Medical | Commercial |
| TrellOss Porous Ti Interbody System | HighRidge Medical | Approved |